ASH 2018 | Mohamad Mohty’s myeloma highlights from ASH 2018
Mohamad Mohty
Mohamad Mohty, MD, PhD, of the University Pierre & Marie Curie, Paris, France, shares his highlights for multiple myeloma (MM) from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Prof. Mohty discusses advancements offering a promising outlook for MM patients, including BiTEs, CAR T-cell therapies, and daratumumab.
Related videos
04:22 Myeloma XI trial: increased progression-free survival
Charlotte Pawlyn
04:22 Pivotal STORM study: selinexor for penta-refractory multiple myeloma
Joshua Richter
04:22 Current challenges for multiple myeloma therapy: 2, 3, 4-drug combinations
Joshua Richter
04:22 Multiple myeloma musings: highlights from 2018 data
Joshua Richter
04:22 An exciting era for CAR T-cell therapy
Mohamad Mohty
